UniProt ID | VTNC_HUMAN | |
---|---|---|
UniProt AC | P04004 | |
Protein Name | Vitronectin | |
Gene Name | VTN | |
Organism | Homo sapiens (Human). | |
Sequence Length | 478 | |
Subcellular Localization | Secreted, extracellular space. | |
Protein Description | Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.; Somatomedin-B is a growth hormone-dependent serum factor with protease-inhibiting activity.. | |
Protein Sequence | MAPLRPLLILALLAWVALADQESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDYTAECKPQVTRGDVFTMPEDEYTVYDDGEEKNNATVHEQVGGPSLTSDLQAQSKGNPEQTPVLKPEEEAPAPEVGASKPEGIDSRPETLHPGRPQPPAEEELCSGKPFDAFTDLKNGSLFAFRGQYCYELDEKAVRPGYPKLIRDVWGIEGPIDAAFTRINCQGKTYLFKGSQYWRFEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGRERVYFFKGKQYWEYQFQHQPSQEECEGSSLSAVFEHFAMMQRDSWEDIFELLFWGRTSAGTRQPQFISRDWHGVPGQVDAAMAGRIYISGMAPRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQNSRRPSRATWLSLFSSEESNLGANNYDDYRMDWLVPATCEPIQSVFFFSGDKYYRVNLRTRRVDTVDPPYPRSIAQYWLGCPAPGHL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
69 | Phosphorylation | VTRGDVFTMPEDEYT CCCCCCEECCCCEEE | 31.50 | 26657352 | |
75 | Sulfation | FTMPEDEYTVYDDGE EECCCCEEEEECCCC | 17.52 | - | |
75 | Sulfation | FTMPEDEYTVYDDGE EECCCCEEEEECCCC | 17.52 | 17558413 | |
75 | Phosphorylation | FTMPEDEYTVYDDGE EECCCCEEEEECCCC | 17.52 | 26657352 | |
76 | Phosphorylation | TMPEDEYTVYDDGEE ECCCCEEEEECCCCC | 15.56 | 26657352 | |
78 | Sulfation | PEDEYTVYDDGEEKN CCCEEEEECCCCCCC | 10.66 | - | |
78 | Phosphorylation | PEDEYTVYDDGEEKN CCCEEEEECCCCCCC | 10.66 | 26657352 | |
78 | Sulfation | PEDEYTVYDDGEEKN CCCEEEEECCCCCCC | 10.66 | 17558413 | |
86 | N-linked_Glycosylation | DDGEEKNNATVHEQV CCCCCCCCCCCEEEC | 48.32 | 18638581 | |
86 | N-linked_Glycosylation | DDGEEKNNATVHEQV CCCCCCCCCCCEEEC | 48.32 | 17623646 | |
88 | Phosphorylation | GEEKNNATVHEQVGG CCCCCCCCCEEECCC | 25.23 | 26657352 | |
88 | O-linked_Glycosylation | GEEKNNATVHEQVGG CCCCCCCCCEEECCC | 25.23 | OGP | |
97 | O-linked_Glycosylation | HEQVGGPSLTSDLQA EEECCCCCHHHHHHH | 47.78 | OGP | |
99 | O-linked_Glycosylation | QVGGPSLTSDLQAQS ECCCCCHHHHHHHHH | 25.24 | OGP | |
100 | O-linked_Glycosylation | VGGPSLTSDLQAQSK CCCCCHHHHHHHHHC | 41.43 | OGP | |
106 | Phosphorylation | TSDLQAQSKGNPEQT HHHHHHHHCCCCCCC | 45.61 | 29759185 | |
130 | O-linked_Glycosylation | PAPEVGASKPEGIDS CCCCCCCCCCCCCCC | 42.70 | OGP | |
130 | Phosphorylation | PAPEVGASKPEGIDS CCCCCCCCCCCCCCC | 42.70 | 26657352 | |
137 | Phosphorylation | SKPEGIDSRPETLHP CCCCCCCCCCCCCCC | 48.06 | 27130503 | |
141 | O-linked_Glycosylation | GIDSRPETLHPGRPQ CCCCCCCCCCCCCCC | 32.80 | OGP | |
141 | Phosphorylation | GIDSRPETLHPGRPQ CCCCCCCCCCCCCCC | 32.80 | 27130503 | |
157 | Phosphorylation | PAEEELCSGKPFDAF CCHHHHHCCCCCCCC | 63.58 | 24505115 | |
169 | N-linked_Glycosylation | DAFTDLKNGSLFAFR CCCEECCCCCEEEEE | 53.21 | 17623646 | |
169 | N-linked_Glycosylation | DAFTDLKNGSLFAFR CCCEECCCCCEEEEE | 53.21 | 17623646 | |
171 | Phosphorylation | FTDLKNGSLFAFRGQ CEECCCCCEEEEECC | 29.70 | 22817900 | |
179 | Phosphorylation | LFAFRGQYCYELDEK EEEEECCEEEEECHH | 10.38 | - | |
218 | Acetylation | TRINCQGKTYLFKGS EEEECCCCEEEECCC | 14.23 | 27178108 | |
219 | Phosphorylation | RINCQGKTYLFKGSQ EEECCCCEEEECCCE | 32.08 | 24505115 | |
220 | Phosphorylation | INCQGKTYLFKGSQY EECCCCEEEECCCEE | 17.39 | 24505115 | |
225 | Phosphorylation | KTYLFKGSQYWRFED CEEEECCCEEEEEEC | 22.23 | 24505115 | |
227 | Phosphorylation | YLFKGSQYWRFEDGV EEECCCEEEEEECCC | 10.55 | 24505115 | |
239 | Phosphorylation | DGVLDPDYPRNISDG CCCCCCCCCCCCCCC | 14.96 | 24505115 | |
242 | N-linked_Glycosylation | LDPDYPRNISDGFDG CCCCCCCCCCCCCCC | 33.34 | 17623646 | |
242 | N-linked_Glycosylation | LDPDYPRNISDGFDG CCCCCCCCCCCCCCC | 33.34 | 17623646 | |
244 | Phosphorylation | PDYPRNISDGFDGIP CCCCCCCCCCCCCCC | 34.92 | 24505115 | |
275 | Acetylation | RERVYFFKGKQYWEY CCEEEEEECCEEEEE | 56.13 | 27178108 | |
282 | Sulfation | KGKQYWEYQFQHQPS ECCEEEEEEECCCCC | 10.65 | - | |
282 | Sulfation | KGKQYWEYQFQHQPS ECCEEEEEEECCCCC | 10.65 | - | |
312 | Phosphorylation | FAMMQRDSWEDIFEL HHHHHCCCHHHHHHH | 34.26 | 25072903 | |
325 | Phosphorylation | ELLFWGRTSAGTRQP HHHHCCCCCCCCCCC | 20.99 | 27251275 | |
355 | Phosphorylation | AAMAGRIYISGMAPR HHHCCCEEEECCCCC | 6.41 | 29691806 | |
357 | Phosphorylation | MAGRIYISGMAPRPS HCCCEEEECCCCCCC | 12.92 | 28270605 | |
364 | Phosphorylation | SGMAPRPSLAKKQRF ECCCCCCCHHHHHHH | 42.09 | 29691806 | |
381 | Phosphorylation | RNRKGYRSQRGHSRG HCCCCCHHHCCCCCC | 18.75 | 22817900 | |
386 | Phosphorylation | YRSQRGHSRGRNQNS CHHHCCCCCCCCCCC | 38.97 | 22817900 | |
393 | Phosphorylation | SRGRNQNSRRPSRAT CCCCCCCCCCCCHHH | 21.65 | 22817900 | |
397 | Phosphorylation | NQNSRRPSRATWLSL CCCCCCCCHHHHHHH | 32.51 | 1696913 | |
400 | Phosphorylation | SRRPSRATWLSLFSS CCCCCHHHHHHHHCC | 26.31 | 28270605 | |
403 | Phosphorylation | PSRATWLSLFSSEES CCHHHHHHHHCCCCC | 20.94 | 29691806 | |
406 | Phosphorylation | ATWLSLFSSEESNLG HHHHHHHCCCCCCCC | 41.98 | 26657352 | |
407 | Phosphorylation | TWLSLFSSEESNLGA HHHHHHCCCCCCCCC | 37.74 | 26657352 | |
410 | Phosphorylation | SLFSSEESNLGANNY HHHCCCCCCCCCCCC | 33.05 | 26657352 | |
417 | Sulfation | SNLGANNYDDYRMDW CCCCCCCCCCCCCEE | 15.25 | - | |
417 | Sulfation | SNLGANNYDDYRMDW CCCCCCCCCCCCCEE | 15.25 | - | |
420 | Phosphorylation | GANNYDDYRMDWLVP CCCCCCCCCCEEECC | 12.63 | - | |
420 | Sulfation | GANNYDDYRMDWLVP CCCCCCCCCCEEECC | 12.63 | - | |
420 | Sulfation | GANNYDDYRMDWLVP CCCCCCCCCCEEECC | 12.63 | - | |
429 | O-linked_Glycosylation | MDWLVPATCEPIQSV CEEECCCCCCCEEEE | 16.01 | OGP | |
456 | Phosphorylation | LRTRRVDTVDPPYPR CCCCCCCCCCCCCCC | 24.77 | 23403867 | |
461 | Phosphorylation | VDTVDPPYPRSIAQY CCCCCCCCCCCHHHH | 19.37 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
69 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
69 | T | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
69 | T | Phosphorylation | Kinase | CK2 | - | Uniprot |
69 | T | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
76 | T | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
76 | T | Phosphorylation | Kinase | CK2 | - | Uniprot |
76 | T | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
76 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
381 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
381 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
386 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
393 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
393 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
397 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
397 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
397 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
397 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
397 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
397 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
393 | Phosphorylation | 400 (7) | T ⇒ M | rs704 |
| 25080503 |
397 | Phosphorylation | 400 (3) | T ⇒ M | rs704 |
| 25080503 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-86; ASN-169 AND ASN-242,AND MASS SPECTROMETRY. | |
"Determination of the sites of tyrosine O-sulfation in peptides andproteins."; Yu Y., Hoffhines A.J., Moore K.L., Leary J.A.; Nat. Methods 4:583-588(2007). Cited for: SULFATION AT TYR-75 AND TYR-78, PHOSPHORYLATION AT SER-312,GLYCOSYLATION AT ASN-86, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-86; ASN-169 AND ASN-242,AND MASS SPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-86; ASN-169 AND ASN-242,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"An initial characterization of the serum phosphoproteome."; Zhou W., Ross M.M., Tessitore A., Ornstein D., Vanmeter A.,Liotta L.A., Petricoin E.F. III; J. Proteome Res. 8:5523-5531(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, TISSUE SPECIFICITY,AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"Determination of the sites of tyrosine O-sulfation in peptides andproteins."; Yu Y., Hoffhines A.J., Moore K.L., Leary J.A.; Nat. Methods 4:583-588(2007). Cited for: SULFATION AT TYR-75 AND TYR-78, PHOSPHORYLATION AT SER-312,GLYCOSYLATION AT ASN-86, AND MASS SPECTROMETRY. | |
"Phosphoproteomic analysis of the human pituitary."; Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; Pituitary 9:109-120(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-171, AND MASSSPECTROMETRY. | |
"The phosphorylation of the two-chain form of vitronectin by proteinkinase A is heparin dependent."; Chain D., Korc-Grodzicki B., Kreizman T., Shaltiel S.; FEBS Lett. 269:221-225(1990). Cited for: PHOSPHORYLATION AT SER-397. | |
"Phosphorylation of vitronectin by a protein kinase in human plasma.Identification of a unique phosphorylation site in the heparin-bindingdomain."; McGuire E.A., Peacock M.E., Inhorn R.C., Siegel N.R., Tollefsen D.M.; J. Biol. Chem. 263:1942-1945(1988). Cited for: PROTEIN SEQUENCE OF 393-400, AND PHOSPHORYLATION AT SER-397. | |
"Phosphorylation of vitronectin by casein kinase II. Identification ofthe sites and their promotion of cell adhesion and spreading."; Seger D., Gechtman Z., Shaltiel S.; J. Biol. Chem. 273:24805-24813(1998). Cited for: PHOSPHORYLATION AT THR-69 AND THR-76, AND MUTAGENESIS OF THR-69 ANDTHR-76. | |
Sulfation | |
Reference | PubMed |
"Determination of the sites of tyrosine O-sulfation in peptides andproteins."; Yu Y., Hoffhines A.J., Moore K.L., Leary J.A.; Nat. Methods 4:583-588(2007). Cited for: SULFATION AT TYR-75 AND TYR-78, PHOSPHORYLATION AT SER-312,GLYCOSYLATION AT ASN-86, AND MASS SPECTROMETRY. |